Our RELATIVE RETURNS
Our ALPHA on a beta of 1.00
Each week we pick 10 companies
, from over 400 companies we follow. View our list of ranked companies here.
Numbers above updated weekly, based on last 12 months.
Pack of Charts #42
Pack of charts is a weekly section where we pick a few of the largest companies we follow, from our list of over 400 companies, and show you our forward looking AOI rank estimates.
This week we take a look at ABT, ACN, CMCSA, COST, CVX, DIS, FB, INTC, MA, MDT, MSFT, NFLX, PFE, PM, PYPL, T, UNH and XOM.
ABT (Abbott Laboratories)
We expect a broad weakening of ABT.
ACN (Accenture plc)
Overall weakening of ACN expected.
CMCSA (Comcast Corp)
Short-term potential to be replaced with negative ranking outlook on CMCSA.
COST (Costco Wholesale Corp)
Short-term potential to be replaced with negative ranking outlook on COST.
CVX (Chevron Corp)
Short- and medium-term weakness in CVX to be replaced with strength long-term.
DIS (Walt Disney Co)
Short- and long-term rankings predicted up on DIS with medium-term decline.
FB (Facebook Inc)
Broad rank reduction ahead for FB predicted.
INTC (Intel Corp)
Positive medium-term and onwards, but short-term outlook is ranked down on INTC.
MA (Mastercard Inc)
Overall weakening of MA expected.
MDT (Medtronic plc)
While showing strength short-term, we expect otherwise a lower rank for MDT.
MSFT (Microsoft Corp)
We expect a broad weakening of MSFT.
NFLX (Netflix Inc)
NFLX showing depressed short and medium rank relative to higher long-term outlook.
PFE (Pfizer Inc)
While negative medium-term, there's strength shown in short- and long-term PFE rankings.
PM (Philip Morris International Inc)
While showing strength short-term, we expect otherwise a lower rank for PM.
PYPL (PayPal Holdings Inc)
Broad rank reduction ahead for PYPL predicted.
T (At&T Inc)
Uncertainty dominates long-term, but short- and medium-term outlook is up for T.
UNH (Unitedhealth Group Inc)
Negative outlook medium- to long-term for UNH rank, after short-term strength.
XOM (Exxon Mobil Corp)
Short-term weakness is expected in XOM followed by it ranking higher.
The next 10 portfolio
Last 5 years performance for our next 10 portfolio vs its benchmark.
Published on 2020-01-12